Trained as a pharmacist, I specialized in organic chemistry, more particularly in structural determination and semisynthesis from natural compounds. Following my recruitment as a lecturer, I then participated in projects in biological fields using peptide synthesis and conventional organic chemistry techniques. I have also been interested more recently in the study of the stability of active ingredients.
Currently, I participate in medicinal chemistry research projects in the field of cancerology, with the design of small molecules aimed at inhibiting Casein Kinase 2.
- QSAR Model of Indeno[1,2-b]indole Derivatives and Identification of N-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-b]furan-3-carboxamide as a Potent CK2 Inhibitor.
Haidar, S.; Marminon, C.; Aichele, D.; Nacereddine, A.; Zeinyeh, W.; Bouzina, A.; Berredjem M.; Ettouati, L.; Bouaziz, Z.; Le Borgne, M.; Jose, J. Molecules 2020, 25, 97.
- Behaviour of Tetrabenazine in Acid Medium: Reassessment and Impact on Formulation.
Ettouati, L.; Senta-Loys, Z.; Bourgeois, S.; Fenet, B.; Le Borgne, M.; Fessi, H. Pharmaceutics 2019, 11, 44.
- Structure-based design and profiling of novel 17β-HSD14 inhibitors.
Braun, F.; Bertoletti, N.; Möller, G.; Adamski, J.; Frotscher, M.; Guragossian, N.; Alexandra Madeira Gírio, P; Le Borgne, M.; Ettouati, L.; Falson, P.; Müller, S.; Vollmer, G.; Heine, A.; Klebe, G.; Marchais-Oberwinkler, S. Eur. J. Med. Chem. 2018, 155, 61-76.
Robin Birus, Ehab El-Awaad, Laurens Ballentin, Faten Alchab, Dagmar Aichele, Laurent Ettouati, Claudia Götz, Marc Le Borgne, Joachim Jose*